EMA Partners IPO allotment date today: EMA Partners India IPO allotment share allotment will be finalised today (Wednesday, January 22). The investors who applied for the issue can check the EMA ...

EMA Partners India Ltd. launched its initial public offering (IPO) on Jan. 17. The company aims to raise Rs 76 crore from the primary markets. EMA Partners India is an executive search firm offering ...

Kosta Barbarouses scored his 100th A-League goal as an under-strength Wellington Phoenix scored their first win of the year, beating Macarthur FC 2-1 at Campbelltown in Sydney. At the other end of ...

Add videos to your saved list and come back to them any time.

Australian Open 2025 is in full swing and today Round 3 matchups will continue to intrigue the fans all around the world. The No.1 seed from Men's Singles, Jannik Sinner, will be in action today ...

Powered by pickle juice, Holger Rune is showing off improved physical tenacity to kick off the 2025 season, defeating Miomir Kecmanovic, 6-7 (5), 6-3, 4-6, 6-4, 6-4 to book a fourth-round clash ...

Miomir Kecmanovic has reached the round of 16 in two of the last three years in Melbourne and he is now one win away from achieving that once again. The Serbian was impressive last time out as he ...

EMA Partners India IPO worth ₹76 crore is a combination of a fresh share sale of 53.34 lakh shares worth ₹66.14 crore and an offer for sale (OFS) of 7.96 lakh shares, totalling ₹9.87 crore ...

THE ECONOMIC TIMES Indorient Financial Services is acting as the book-running lead manager for the EMA Partners IPO. Meanwhile Bigshare Services is acting as the registrar. The Rs 76 crore SME IPO of ...

13th-seeded Holger Rune will take on Miomir Kecmanovic in the third round of the Australian Open. The Danish player did not have much game time in the leadup to the Melbourne Major. He lost his ...

The FDA approved five fewer novel medicines than in 2023 while the EMA improved its tally by seven. Image credit: Shutterstock / Tamakhin Mykhailo. The US Food and Drug Administration (FDA) has ...